Form 4: Veracyte SVP, General Counsel Annie McGuire Reports Stock Award
SEC Form 4 Filing
Annie McGuire, SVP, General Counsel of Veracyte, Inc., reports the acquisition of 30,200 shares of common stock as restricted stock units.
Summary
- Annie McGuire, SVP, General Counsel of Veracyte, Inc. filed a Form 4 on March 10, 2025.
- The report details a transaction on March 6, 2025, where Ms. McGuire acquired 30,200 shares of Veracyte common stock as restricted stock units.
- These restricted stock units were awarded on March 6, 2025, and vest 25% on March 2, 2026, and then 1/16 per quarter thereafter, contingent upon continued employment.
- Following the reported transaction, Ms. McGuire directly owns 100,508 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, and the sentiment is neutral.
Positives
- The acquisition of restricted stock units aligns the executive's interests with the long-term performance of the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The stock award could have a slightly positive impact on shareholder sentiment as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of transaction: Annie McGuire acquired 30,200 shares of Veracyte common stock as restricted stock units. |
| 03/02/2026 | First vesting date: 25% of the restricted stock units vest. |
| 03/10/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.